Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Dec 1, 2025 9:00 AM ・ Updated Jun 1, 2026 12:17 PM ・ 2 min read ・ Source: PR Times
Standard Chemical Pharmaceutical Co., Ltd. (Stock Code: 1720) announced its financial report for the fourth quarter of 2025. The company's operating revenue for the quarter was NT$7.023 billion, with a net profit after tax of NT$1.256 billion, and basic earnings per share of NT$5.19. The company belongs to the biotechnology and medical industry.
Company Code: 1720 Company Name: Standard Chemical Pharmaceutical Co., Ltd. Industry: Biotechnology and Medical Year/Quarter: 2025 Q4 Basic Earnings Per Share: NT$5.19 Operating Revenue: NT$7.023 billion Net Profit After Tax: NT$1.256 billion
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.